Breast Reconstruction Market by Product and Geography - Forecast and Analysis 2020-2024

世界の乳房再建市場予測・分析2020-2024

◆タイトル:Breast Reconstruction Market by Product and Geography - Forecast and Analysis 2020-2024
◆商品コード:TNV20FB076
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2020年1月
◆ページ数:132
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥262,500見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥315,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥420,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

「乳房再建の世界市場2020-2024」は、乳房再建について市場概要、市場規模、製品別(乳房インプラント、組織エキスパンダー)分析、顧客状況、地域状況、決定フレームワーク、市場の要因・課題、市場トレンド、企業状況、企業分析などを総合的にまとめて調査・分析したものです。
・エグゼクティブサマリー
・レポート範囲
・市場概要
・市場規模
・ファイブフォース分析
・乳房再建の世界市場:製品別(乳房インプラント、組織エキスパンダー)
・顧客状況
・地域状況
・決定フレームワーク
・市場の要因・課題
・市場トレンド
・企業状況
・企業分析

Global Breast Reconstruction Market 2020-2024
Technavio has been monitoring the global breast reconstruction market and it is poised to grow by USD 1.01 billion during 2020-2024, progressing at a CAGR of almost 9% during the forecast period. Our reports on breast reconstruction market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by Rising incidence of breast cancer. In addition, strong research funding is anticipated to boost the growth of the breast reconstruction market as well.

Market Segmentation

Technavio’s global breast reconstruction market is segmented as below:
Product
• Breast Implants
• Tissue Expanders

Geographic segmentation
• Asia
• Europe
• North America
• ROW

Key Trends for breast reconstruction market growth
This study identifies strong research funding as the prime reasons driving the breast reconstruction market growth during the next few years.
Prominent vendors in breast reconstruction market
We provide a detailed analysis of around 25 vendors operating in the breast reconstruction market, including some of the vendors such as Allergan Plc, CEREPLAS, Establishment Labs Holdings Inc., GC Aesthetics Inc., Groupe SEBBIN SAS, Ideal Implant Inc., Johnson & Johnson, Laboratories Arion, POLYTECH Health & Aesthetics GmbH and Sientra Inc.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit -https://www.technavio.com/report/breast-reconstruction-market-industry-analysis

About Technavio
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

【資料の目次】

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
• Value Chain Analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2019
• Market size and forecast 2019-2024
• Market Outlook
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: CUSTOMER LANDSCAPE
PART 07: MARKET SEGMENTATION BY PRODUCT
• Market segmentation by product
• Comparison by product
• Breast implants – Market size and forecast 2019-2024
• Tissue expanders – Market size and forecast 2019-2024
• Market opportunity by product
PART 08: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America – Market size and forecast 2019-2024
• Europe – Market size and forecast 2019-2024
• Asia – Market size and forecast 2019-2024
• ROW – Market size and forecast 2019-2024
• Key leading countries
• Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 11: MARKET TRENDS
• Strong research funding
• Increasing number of awareness campaigns
• Growing popularity of DBT
PART 12: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive scenario
PART 13: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Allergan Plc
• CEREPLAS
• Establishment Labs Holdings Inc.
• GC Aesthetics Inc.
• Groupe SEBBIN SAS
• Ideal Implant Inc.
• Johnson & Johnson
• Laboratories Arion
• POLYTECH Health & Aesthetics GmbH
• Sientra Inc.
PART 14: APPENDIX
• Research methodology
• List of abbreviations
• Definition of market positioning of vendors
PART 15: EXPLORE TECHNAVIO


Exhibit 01: Global healthcare supplies market
Exhibit 02: Segments of global healthcare supplies market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Vendors: Key offerings
Exhibit 06: Market definition – Inclusions and exclusions checklist
Exhibit 07: Market size 2019
Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
Exhibit 10: Five forces analysis 2019
Exhibit 11: Five forces analysis 2024
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2019
Exhibit 18: Customer landscape
Exhibit 19: Product – Market share 2019-2024 (%)
Exhibit 20: Comparison by product
Exhibit 21: Breast implants – Market size and forecast 2019-2024 ($ millions)
Exhibit 22: Breast implants – Year-over-year growth 2020-2024 (%)
Exhibit 23: Tissue expanders – Market size and forecast 2019-2024 ($ millions)
Exhibit 24: Tissue expanders – Year-over-year growth 2020-2024 (%)
Exhibit 25: Market opportunity by product
Exhibit 26: Market share by geography 2019-2024 (%)
Exhibit 27: Geographic comparison
Exhibit 28: North America – Market size and forecast 2019-2024 ($ millions)
Exhibit 29: North America – Year-over-year growth 2020-2024 (%)
Exhibit 30: Europe – Market size and forecast 2019-2024 ($ millions)
Exhibit 31: Europe – Year-over-year growth 2020-2024 (%)
Exhibit 32: Asia – Market size and forecast 2019-2024 ($ millions)
Exhibit 33: Asia – Year-over-year growth 2020-2024 (%)
Exhibit 34: ROW – Market size and forecast 2019-2024 ($ millions)
Exhibit 35: ROW – Year-over-year growth 2020-2024 (%)
Exhibit 36: Key leading countries
Exhibit 37: Market opportunity
Exhibit 38: Estimated breast cancer rates in 2018
Exhibit 39: Cosmetic surgical procedures
Exhibit 40: Impact of drivers and challenges
Exhibit 41: Organizations conducting awareness campaigns
Exhibit 42: Vendor landscape
Exhibit 43: Landscape disruption
Exhibit 44: Vendors covered
Exhibit 45: Vendor classification
Exhibit 46: Market positioning of vendors
Exhibit 47: Allergan Plc – Vendor overview
Exhibit 48: Allergan Plc – Business segments
Exhibit 49: Allergan Plc – Organizational developments
Exhibit 50: Allergan Plc – Segment focus
Exhibit 51: Allergan Plc – Key offerings
Exhibit 52: CEREPLAS – Vendor overview
Exhibit 53: CEREPLAS – Product segments
Exhibit 54: CEREPLAS – Key offerings
Exhibit 55: Establishment Labs Holdings Inc. – Vendor overview
Exhibit 56: Establishment Labs Holdings Inc. – Business segments
Exhibit 57: Establishment Labs Holdings Inc. – Organizational developments
Exhibit 58: Establishment Labs Holdings Inc. – Key offerings
Exhibit 59: GC Aesthetics Inc. – Vendor overview
Exhibit 60: GC Aesthetics Inc. – Product segments
Exhibit 61: GC Aesthetics Inc. – Organizational developments
Exhibit 62: GC Aesthetics Inc. – Key offerings
Exhibit 63: Groupe SEBBIN SAS – Vendor overview
Exhibit 64: Groupe SEBBIN SAS – Product segments
Exhibit 65: Groupe SEBBIN SAS – Key offerings
Exhibit 66: Ideal Implant Inc. – Vendor overview
Exhibit 67: Ideal Implant Inc. – Key offerings
Exhibit 68: Johnson & Johnson – Vendor overview
Exhibit 69: Johnson & Johnson – Business segments
Exhibit 70: Johnson & Johnson – Organizational developments
Exhibit 71: Johnson & Johnson – Geographic focus
Exhibit 72: Johnson & Johnson – Segment focus
Exhibit 73: Johnson & Johnson – Key offerings
Exhibit 74: Laboratories Arion – Vendor overview
Exhibit 75: Laboratories Arion – Key offerings
Exhibit 76: POLYTECH Health & Aesthetics GmbH – Vendor overview
Exhibit 77: POLYTECH Health & Aesthetics GmbH – Product segments
Exhibit 78: POLYTECH Health & Aesthetics GmbH – Key offerings
Exhibit 79: Sientra Inc. – Vendor overview
Exhibit 80: Sientra Inc. – Business segments
Exhibit 81: Sientra Inc. – Organizational developments
Exhibit 82: Sientra Inc. – Geographic focus
Exhibit 83: Sientra Inc. – Segment focus
Exhibit 84: Sientra Inc. – Key offerings
Exhibit 85: Validation techniques employed for market sizing
Exhibit 86: Definition of market positioning of vendors



【掲載企業】

Allergan Plc, CEREPLAS, Establishment Labs Holdings Inc., GC Aesthetics Inc., Groupe SEBBIN SAS, Ideal Implant Inc., Johnson & Johnson, Laboratories Arion, POLYTECH Health & Aesthetics GmbH, and Sientra Inc.

【免責事項】
※当資料上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当資料に記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当資料上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[世界の乳房再建市場予測・分析2020-2024]についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆